Recombinant multi-species PRB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the heterogeneous family of basic, proline-rich, human salivary glycoproteins. The encoded preproprotein undergoes proteolytic processing to generate one or more mature isoforms before secretion from the parotid glands. Multiple alleles of this gene exhibiting variations in the length of the tandem repeats, polymorphic cleavage sites and polymorphic stop codons have been identified. This gene is located in a cluster of closely related salivary proline-rich proteins on chromosome 12. [provided by RefSeq, Oct 2015]
The Alternative Names of target: Basic salivary proline-rich protein 2,Con1 glycoprotein,IB-9,PRB2,PRPPRB1,Ps,Salivary proline-rich protein,cP7
Go
to PRB2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1201-Ag-1/ GM-Tg-hg-SE1201-Ag-2 | Human PRB2 protein | Human |
| GM-Tg-rg-SE1201-Ag-1/ GM-Tg-rg-SE1201-Ag-2 | Rat PRB2 protein | Rat |
| GM-Tg-mg-SE1201-Ag-1/ GM-Tg-mg-SE1201-Ag-2 | Mouse PRB2 protein | Mouse |
| GM-Tg-cynog-SE1201-Ag-1/ GM-Tg-cynog-SE1201-Ag-2 | Cynomolgus/Rhesus macaque PRB2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1201-Ag-1/ GM-Tg-felg-SE1201-Ag-2 | Feline PRB2 protein | Feline |
| GM-Tg-cang-SE1201-Ag-1/ GM-Tg-cang-SE1201-Ag-2 | Canine PRB2 protein | Canine |
| GM-Tg-bovg-SE1201-Ag-1/ GM-Tg-bovg-SE1201-Ag-2 | Bovine PRB2 protein | Bovine |
| GM-Tg-equg-SE1201-Ag-1/ GM-Tg-equg-SE1201-Ag-2 | Equine PRB2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1201-Ag-1/ GM-Tg-hg-SE1201-Ag-2;
GM-Tg-rg-SE1201-Ag-1/ GM-Tg-rg-SE1201-Ag-2;
GM-Tg-mg-SE1201-Ag-1/ GM-Tg-mg-SE1201-Ag-2; GM-Tg-cynog-SE1201-Ag-1/ GM-Tg-cynog-SE1201-Ag-2; GM-Tg-felg-SE1201-Ag-1/ GM-Tg-felg-SE1201-Ag-2; GM-Tg-cang-SE1201-Ag-1/ GM-Tg-cang-SE1201-Ag-2; GM-Tg-bovg-SE1201-Ag-1/ GM-Tg-bovg-SE1201-Ag-2; GM-Tg-equg-SE1201-Ag-1/ GM-Tg-equg-SE1201-Ag-2 |
| Products Name | PRB2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PRB2 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRB2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.